Baker Biotech Capital (GP), LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is a 10% Owner in PHARMACYCLICS INC ($PCYC) and a 10% Owner in VIROPHARMA INC ($VPHM) and a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a 10% Owner in ADOLOR CORP ($ADLR) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in Ocera Therapeutics, Inc. ($TZYM).

Address: 667 MADISON AVENUE, 21ST FLOOR NEW YORK US 10065 NY

Companies in which Baker Biotech Capital (GP), LLC is an Insider

ADOLOR CORP

Trading Symbol: ADLR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Jan 03 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GENOMIC HEALTH INC

Trading Symbol: GHDX
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 1,484,977 shares
Current Value: $40,822,018
Latest Transaction: Mar 09 2012
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ocera Therapeutics, Inc.

Trading Symbol: TZYM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 232,011 shares
Latest Transaction: Mar 14 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PHARMACYCLICS INC

Trading Symbol: PCYC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 557,211 shares
Latest Transaction: Feb 14 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Seagen Inc.

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 4,966,001 shares
Current Value: $301,883,201
Latest Transaction: Jan 04 2012
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SYNAGEVA BIOPHARMA CORP

Trading Symbol: GEVA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 1,736,065 shares
Latest Transaction: Jan 09 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

VIROPHARMA INC

Trading Symbol: VPHM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 1,966,090 shares
Latest Transaction: Dec 16 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC

Sentiment: All, ADLR, GHDX, TZYM, PCYC, SGEN, GEVA, VPHM

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 14 2012	TZYM	Ocera Therapeutics ...	Baker Biotech Capital (GP), LL ...	10% Owner	Buy	P	3.01	4,592	13,801	232,011	227.4 K to 232 K (+2.02 %)
Mar 14 2012	TZYM	Ocera Therapeutics ...	Baker Biotech Capital (GP), LL ...	10% Owner	Buy	P	2.99	7,484	22,370	227,419	219.9 K to 227.4 K (+3.40 %)
Mar 14 2012	TZYM	Ocera Therapeutics ...	Baker Biotech Capital (GP), LL ...	10% Owner	Buy	P	2.96	15,599	46,143	219,935	204.3 K to 219.9 K (+7.63 %)
Mar 14 2012	TZYM	Ocera Therapeutics ...	Baker Biotech Capital (GP), LL ...	10% Owner	Buy	P	2.55	56,187	143,277	204,336	148.1 K to 204.3 K (+37.93 %)
Mar 14 2012	TZYM	Ocera Therapeutics ...	Baker Biotech Capital (GP), LL ...	10% Owner	Buy	P	2.34	32,155	75,230	148,149	116 K to 148.1 K (+27.72 %)
Mar 14 2012	TZYM	Ocera Therapeutics ...	Baker Biotech Capital (GP), LL ...	10% Owner	Buy	P	1.87	4,363	8,159	115,994	111.6 K to 116 K (+3.91 %)
Mar 14 2012	TZYM	Ocera Therapeutics ...	Baker Biotech Capital (GP), LL ...	10% Owner	Buy	P	1.89	1,601	3,019	111,631	110 K to 111.6 K (+1.46 %)

View all Baker Biotech Capital (GP), LLC insider transactions.